Leadership & Pay ·
Guardant Health appoints former Dexcom CEO Kevin Sayer to board and names Robert Parks as chief accounting officer
GHGuardant Health, Inc.
Guardant Health appointed Kevin R. Sayer, former CEO of Dexcom, as a Class II director effective November 2, 2026, with the Board increasing its size to 11 members. Sayer receives a $500,000 initial restricted stock unit award and a $60,000 annual cash retainer. The company also appointed Robert A. Parks as Chief Accounting Officer and principal accounting officer; Parks previously held similar roles at Fortrea Holdings, SailPoint Technologies, NetApp, and Syneos Health. Guardant Health is a precision oncology company providing liquid biopsy tests and AI analytics for cancer care.